Liver fibrosis in adults with Fontan palliation: Do common screening studies predict disease severity?

Ofei SY, Gariepy C, Hanje J, Sisk T, Daniels CJ …

Keywords — author-chosen Congenital heart disease, FibroSure, Fontan, Hepatic fibrosis, Single ventricle

MeSH — NLM indexing Adolescent Adult Female Fontan Procedure / adverse effects Fontan Procedure / trends Humans Liver Cirrhosis / diagnosis Liver Cirrhosis / etiology Male Mass Screening / trends Predictive Value of Tests Severity of Illness Index Young Adult

Staff actions

Download PDF

Files are for authorised use within BioPredictive partner channels only.

Fibrotest Actitest Letter Independent Group United States

Authors (6)

Ofei SY — Nationwide Children's Hospital/The Ohio State University, Department of Pediatrics, Division of Gastroenterology, Hepatology and Nutrition, 700 Children's Drive, Columbus, OH 43205, USA. Electronic address: sylvia.ofei@nationwidechildrens.org.
Gariepy C — Nationwide Children's Hospital/The Ohio State University, Department of Pediatrics, Division of Gastroenterology, Hepatology and Nutrition, 700 Children's Drive, Columbus, OH 43205, USA. Electronic address: cheryl.gariepy@nationwidechildrens.org.
Hanje J — Wexner Medical Center/The Ohio State University, Department of Internal Medicine, Division of Gastroenterology, Hepatology and Nutrition, 370 West 9th Avenue, Columbus, OH 43210, USA. Electronic address: james.hanje@osumc.edu.
Sisk T — Nationwide Children's Hospital/The Ohio State University, The Columbus Ohio Adult Congenital Heart Disease Program (COACH), The Heart Center, Division of Pediatric Cardiology, 700 Children's Drive, Columbus, OH 43205, USA. Electronic address: tracey.sisk@nationwidechildrens.org.
Daniels CJ — Nationwide Children's Hospital/The Ohio State University, The Columbus Ohio Adult Congenital Heart Disease Program (COACH), The Heart Center, Division of Pediatric Cardiology, 700 Children's Drive, Columbus, OH 43205, USA; Wexner Medical Center/The Ohio State University, Department of Internal Medicine, Division of Cardiovascular Medicine, 370 West 9th Avenue, Columbus, OH 43210, USA. Electronic address: curt.daniels@nationwidechildrens.org.

Ofei SY — Nationwide Children's Hospital/The Ohio State University, Department of Pediatrics, Division of Gastroenterology, Hepatology and Nutrition, 700 Children's Drive, Columbus, OH 43205, USA. Electronic address: sylvia.ofei@nationwidechildrens.org.
Gariepy C — Nationwide Children's Hospital/The Ohio State University, Department of Pediatrics, Division of Gastroenterology, Hepatology and Nutrition, 700 Children's Drive, Columbus, OH 43205, USA. Electronic address: cheryl.gariepy@nationwidechildrens.org.
Hanje J — Wexner Medical Center/The Ohio State University, Department of Internal Medicine, Division of Gastroenterology, Hepatology and Nutrition, 370 West 9th Avenue, Columbus, OH 43210, USA. Electronic address: james.hanje@osumc.edu.
Sisk T — Nationwide Children's Hospital/The Ohio State University, The Columbus Ohio Adult Congenital Heart Disease Program (COACH), The Heart Center, Division of Pediatric Cardiology, 700 Children's Drive, Columbus, OH 43205, USA. Electronic address: tracey.sisk@nationwidechildrens.org.
Daniels CJ — Nationwide Children's Hospital/The Ohio State University, The Columbus Ohio Adult Congenital Heart Disease Program (COACH), The Heart Center, Division of Pediatric Cardiology, 700 Children's Drive, Columbus, OH 43205, USA; Wexner Medical Center/The Ohio State University, Department of Internal Medicine, Division of Cardiovascular Medicine, 370 West 9th Avenue, Columbus, OH 43210, USA. Electronic address: curt.daniels@nationwidechildrens.org.
Zaidi AN — Nationwide Children's Hospital/The Ohio State University, The Columbus Ohio Adult Congenital Heart Disease Program (COACH), The Heart Center, Division of Pediatric Cardiology, 700 Children's Drive, Columbus, OH 43205, USA; Wexner Medical Center/The Ohio State University, Department of Internal Medicine, Division of Cardiovascular Medicine, 370 West 9th Avenue, Columbus, OH 43210, USA. Electronic address: azaidi@montefiore.org.

Citation

Ofei SY, Gariepy C, Hanje J, Sisk T, Daniels CJ, Zaidi AN. Liver fibrosis in adults with Fontan palliation: Do common screening studies predict disease severity?. Int J Cardiol. 2015;181:174-5. doi:10.1016/j.ijcard.2014.12.031.

Identifiers

DOI: 10.1016/j.ijcard.2014.12.031
PMID: 25528305

Tests

Liver diseases

Liver injuries

Comparisons

Subjects

Region

Liver fibrosis in adults with Fontan palliation: Do common screening studies predict disease severity?

More on the same topic

Diagnostic performance of FibroTest-ActiTest, transient elastography, and the fibrosis-4 index in patients with autoimmune hepatitis using histological reference.

Metabolic dysfunction-associated steatotic liver disease (MASLD) biomarkers and progression of lower limb arterial calcification in patients with type 2 diabetes: a prospective cohort study.

Toward non-invasive assessment strategies in autoimmune hepatitis.

Accuracy of prognostic serological biomarkers in predicting liver fibrosis severity in people with metabolic dysfunction-associated steatotic liver disease: a meta-analysis of over 40,000 participants.

Non-alcoholic fatty liver disease biomarkers estimate cardiovascular risk based on coronary artery calcium score in type 2 diabetes: a cross-sectional study with two independent cohorts.

Novel Biomarkers of Grade I Left Ventricular Diastolic Dysfunction in Type 2 Diabetes Patients with Metabolic-Dysfunction-Associated Steatotic Liver Disease.